Canadian Institutes of Health Research Institute of Infection and Immunity

Canadian Institutes of Health Research Institute of Infection and Immunity
Name	Institute of Infection and Immunity
Parent	Canadian Institutes of Health Research
Established	2000
Location	Ottawa, Ontario
Focus	Infectious diseases, immunology, vaccines, antimicrobial resistance

Canadian Institutes of Health Research Institute of Infection and Immunity The Institute of Infection and Immunity is a biomedical research institute affiliated with the Canadian Institutes of Health Research that coordinates, funds, and promotes research on infectious diseases, immunology, and vaccinology across Canada. It supports investigations into pathogens, host responses, and public health interventions, bridging translational science and policy through partnerships with academic, clinical, and governmental institutions. The Institute interfaces with national and international organizations to address priority threats such as pandemic influenza, antimicrobial resistance, and emerging zoonoses.

Overview

The Institute operates within the structure of the Canadian Institutes of Health Research alongside sister institutes such as the Institute of Cancer Research and the Institute of Neurosciences, Mental Health and Addiction, aligning its mandate with national strategies including the Pan-Canadian Public Health Network and the Public Health Agency of Canada. Its remit encompasses basic science, translational research, clinical trials, and population health studies related to pathogens like HIV/AIDS, SARS-CoV-2, and tuberculosis, and intersects with initiatives led by organizations such as the World Health Organization, the Gavi, the Vaccine Alliance, and the Bill & Melinda Gates Foundation. The Institute maintains links to major Canadian research universities including the University of Toronto, the McGill University Health Centre, the University of British Columbia, and the Université de Montréal.

Research Priorities and Programs

Research priorities include vaccine development, immune response characterization, pathogen genomics, and antimicrobial resistance (AMR). Programs often target translational pipelines connecting laboratories at institutions like the National Microbiology Laboratory (Canada) with clinical networks such as the Canadian Nosocomial Infection Surveillance Program and cohorts established by the Canadian Longitudinal Study on Aging. Specific efforts span collaborations with consortia including the Human Vaccines Project, the International Severe Acute Respiratory and Emerging Infection Consortium, and the Canadian COVID-19 Immunity Task Force. Funding calls emphasize cross-disciplinary teams drawn from centers such as the The Hospital for Sick Children and the Montreal Clinical Research Institute, and engage technology platforms from companies and institutes like VIDO-InterVac and the Vector Institute.

Funding and Grants

The Institute administers targeted funding competitions, strategic grants, and training awards through the Canadian Institutes of Health Research funding mechanisms, coordinating with federal programs such as the Strategic Innovation Fund and partners like the Natural Sciences and Engineering Research Council on multidisciplinary projects. Grant programs support faculty at universities including the University of Calgary and the Dalhousie University and fund networks that include hospitals such as St. Michael's Hospital (Toronto) and research institutes like the Ottawa Hospital Research Institute. During public health emergencies, the Institute has mobilized rapid-response funding similar to initiatives by the Bill & Melinda Gates Foundation and the Wellcome Trust to accelerate trials akin to those run by the RECOVERY Trial and vaccine evaluations comparable to Operation Warp Speed collaborations.

Organizational Structure and Leadership

Governance aligns with the CIHR Institute model, with an Institute Advisory Board composed of researchers, clinicians, and patient partners drawn from entities such as the Canadian Medical Association, the Association of Medical Microbiology and Infectious Disease Canada, and academic leaders from institutions including Queen's University and the University of Alberta. Directors liaise with national bodies such as the Treasury Board of Canada and the Health Canada regulatory framework to ensure alignment with policy. Scientific directors and program officers collaborate with investigators from research hubs like the BC Centre for Disease Control and international partners at the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control.

Partnerships and Collaborations

The Institute fosters partnerships with provincial health authorities including Ontario Ministry of Health and Alberta Health Services, academic consortia such as the Canadian Network on Hepatitis C, and international alliances like the Coalition for Epidemic Preparedness Innovations. Collaborative projects link investigators at institutions such as the Sunnybrook Health Sciences Centre, the Jewish General Hospital (Montreal), and the Children's Hospital of Eastern Ontario with industry partners, philanthropic organizations including the Canadian Cancer Society (for intersecting immuno-oncology work), and regulatory agencies including Health Canada. It also engages with Indigenous health organizations and networks such as the National Collaborating Centre for Indigenous Health to support culturally appropriate infectious disease research.

Impact and Notable Contributions

The Institute has contributed to advances in vaccine research, antimicrobial stewardship, and outbreak response, supporting teams that have published in journals such as The Lancet, Nature, and The New England Journal of Medicine. Its funding enabled Canadian participation in major trials and surveillance programs for H1N1, Ebola, and COVID-19, and bolstered genomic sequencing capacity at facilities like the National Microbiology Laboratory (Canada) and provincial laboratories. Notable collaborations include work with the Canadian Institutes of Health Research Institute of Population and Public Health on population-level strategies, partnerships with the Canadian Institutes of Health Research Institute of Genetics on host genomics, and support for trainees who later joined institutions such as the Harvard Medical School, University of Oxford, and the Johns Hopkins Bloomberg School of Public Health.

Category:Canadian medical research institutes